Riccardo Mazza։ Personalized Anticoagulation in Atrial Fibrillation
Riccardo Mazza, Cardiology Resident at University Vita-Salute San Raffaele, shared a post on LinkedIn about a recent article he co-authored with Cosmo Godino, adding:
՛՛Our response to the Letter to the Editor by Magdelijns et al. has been published in the Journal of Thrombosis and Haemostasis.
The concept of ‘one-size-fits-all’ anticoagulation may have limitations in contemporary AF management.
Personalized anticoagulation is progressively moving from theoretical consideration to clinical discussion.
We are grateful for the ongoing scientific discussion and look forward to the results of the DOAC-FRAIL trial.՛՛
Title: Plasma levels measurement of the 4 direct oral anticoagulants in patients with atrial fibrillation at the time of acute thromboembolic and bleeding events: reply
Authors: Cosmo Godino, Riccardo Mazza
Read the Full Article on Journal of Thrombosis and Haemostasis․
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 23, 2026, 17:51Gurpreet Kaurr: A Proud Milestone in Haematology and Oncology
-
Aug 23, 2026, 17:33Kathrine Kaspersen: How Voluntary Plasma Donors Helped Transform Denmark’s Plasma Supply
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia